Randomized, Multi-center, Open-label, Study of PR104 Versus PR104/Docetaxel in Non-Small Cell Lung Cancer (NSCLC)
Clinical trial NCT00862134 · TERMINATED
Trial details
- NCT number
- NCT00862134
- Sponsor
- Proacta, Incorporated
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2009-03-01
- Primary completion
- 2010-01-01
- Enrollment
- 42
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.